Alimera sciences investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of alimera sciences, inc. - alim

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of alimera sciences, inc. (nasdaqgm: alim) to ani pharmaceuticals, inc. (nasdaqgm: anip). under the terms of the proposed transaction, shareholders of alimera will receive $5.50 per share in cash at closing and one non-tradable contingent value right representing the right to receive up to $0.50 per share upon th.
ANIP Ratings Summary
ANIP Quant Ranking